Related by context. All words. (Click for frequent words.) 79 Receives Conditional 78 Announces Commencement 78 Updates Status 77 Announce Receipt 77 Announces Successful Completion 77 Shareholders Approve Acquisition 77 Completes Purchase 77 Provides Updates 77 Announces Receipt 77 Receives Approval 76 Announces Termination 76 Successfully Closes 76 Receives Patent 76 Completes Previously Announced 76 Obtains FDA 76 Obtains Approval 76 Secures Financing 76 Announce Completion 76 Announces Shareholder Approval 76 Completes Financing 76 Receives Notice 76 Files Shelf Registration Statement 76 Receives Notification 76 Closes Previously Announced 75 Closes Acquisition 75 Announces Initiation 75 Shareholders Approve Merger 75 Announces Completion 75 Announces Acquisition 75 Enters Into Agreement 75 Reports Positive 75 Submits Application 75 Closes Sale 75 Completes Initial 75 Closes Second Tranche 75 Announces Issuance 75 Subsidiary Receives 75 Announces Resumption 75 Amends Terms 74 Consummates 74 Provides Update Regarding 74 Completes Acquisition 74 Completes Divestiture 74 Subsidiary Acquires 74 Completes Private Placement 74 Successfully Completes 74 Announces Cancellation 74 Finalizes Acquisition 74 Announces Proposed 74 Announces Closing 74 Executes Agreement 74 Reports Receipt 74 Receives Favorable 74 Completes Acquisitions 74 Announce Merger Agreement 74 Shareholders Approve 74 Finalizes Agreement 74 Enters Agreement 74 Announces FDA Clearance 74 Jointly Announce 74 Announces Positive 74 Announces Successful 74 Receives Positive 74 Obtains Regulatory 74 Receives Conditional Approval 73 Announces Postponement 73 Announces Effective Date 73 Completes Merger 73 Announces Preliminary 73 Acquires Assets 73 Completes Asset 73 Completes Enrollment 73 Increases Ownership 73 Closes Financing 73 Announces Revised 73 Announces Normal Course 73 Receives Unsolicited 73 Receives Shareholder Approval 73 Completes Conversion 73 Updates Shareholders 73 Receives NASDAQ 73 Completes Successful 73 Sign Licensing Agreement 73 Announce Expiration 73 Announces Divestiture 73 Announces Underwriters Exercise 73 Completes Merger With 73 Confirms Receipt 73 Completes Sale 73 Joins OTCQX 73 Provides Clarification 73 Attains 73 Announces Signing 73 Amends Agreement 73 Subsidiary Enters 73 Obtains 73 Stockholders Approve Merger 73 Announces Definitive Agreement 73 Announces Filing 73 Commences Trading 72 Q3 Loss Widens 72 Closes Private Placement 72 Receives Permit 72 Announces Private Placement 72 Strengthens Its 72 Enters Into Definitive Agreement 72 Completes Transaction 72 Announces Non Brokered 72 Acquire Assets 72 Files Patent Application 72 Announces Expanded 72 Acquires Controlling Interest 72 Receives FDA Clearance 72 Sinks Lower 72 Finalizes Purchase 72 Completes Expansion 72 Increases Size 72 IIROC Resume 72 Announces Intention 72 Sign Definitive Agreement 72 Receives Orphan Drug Designation 72 Receives CE 72 Terminates Agreement 72 Jumps Higher 72 Q1 Loss Narrows 72 Presents Positive 72 Stockholders Approve 72 Completes Tender Offer 72 Announces Intent 72 Significantly Expands 72 Gets Approval 72 Adopts Shareholder Rights 72 Announces Stockholder Approval 72 Enters Into Letter 72 Q4 Loss Widens 72 Closes Acquisition Of 72 Provides Update 72 Board Authorizes 72 Enrolls First 72 Initiates Phase II 72 Announces Record Date 72 Q4 Loss Narrows 72 Commences Operations 71 Seeks Approval 71 Exercises Option 71 Announces Redemption 71 Announces Expiration 71 Q3 Loss Narrows 71 Initiates Enrollment 71 Announces Delisting 71 Announce License Agreement 71 Acquires Remaining Interest 71 Announces Stock Repurchase 71 Signs Definitive Agreement 71 Receives Milestone Payment 71 Signs Agreements 71 Voluntarily Withdraw 71 Complete Merger 71 Provides Preliminary 71 Receives Authorization 71 Announce Merger 71 Closes Merger 71 Signs Option Agreement 71 Announces Expansion 71 Announces Cash Dividend 71 Q2 Loss Narrows 71 Receives Confirmation 71 Receives Clearance 71 Receives Fast Track 71 Announces Early Termination 71 Completes Patient Enrollment 71 Regains Compliance 71 Announces Proposed Acquisition 71 Completes Redemption 71 Receives Tentative FDA 71 Regains Compliance With 71 Board Unanimously Rejects 71 Files IND 71 Further Strengthens 71 Announces Reverse Split 71 Extends Expiration Date 71 Expands Scope 71 CRWESelect CRWESelect.com Highlights 71 BayStreet.ca Research Alert 71 IIROC Halt 70 Q2 Loss Widens 70 Announces Favorable 70 Completes Reverse Merger 70 Extends Tender Offer 70 Announces Organizational Changes 70 Renegotiates 70 Commences 70 Signs Licensing Agreement 70 Files Shelf Registration 70 Announces Adjournment 70 Extends Maturity 70 Enters Into Agreements 70 Announce Collaboration Agreement 70 Introduces Enhanced 70 Announces Consummation 70 Receives Approvals 70 Obtains License 70 Announces Licensing Agreement 70 Announce Successful Completion 70 Awarded Patent 70 Announce Definitive Agreement 70 FY# Loss Widens 70 Reacquires 70 Stockholders Approve Acquisition 70 Commence Trading 70 Achieves Milestone 70 Strengthens Position 70 Terminates Contract 70 Announce Commencement 70 Completes Purchase Of 70 Announce Licensing Agreement 70 Clarifies Status 70 Regains NASDAQ 70 Reconfirms 70 Receive Milestone Payment 70 Acquirer Company 70 Inks Pact 70 Initiates Clinical Trial 70 Shareholders Overwhelmingly Approve 70 Secures Additional 70 Terminates Merger Agreement 70 Announce Agreement 70 Completes 70 Wins Approval 70 Shareholders Approve Merger Agreement 70 Regains Full 70 Announces Granting 70 L.P. Announces 70 Completes Refinancing 70 Files Preliminary Prospectus 70 Announces License Agreement 70 FDA Clears 70 Achieves Significant 70 Subsidiary Signs 70 Changes Name 69 Attracting Bullish Investors 69 Signs Merger Agreement 69 Receives Commitment 69 Announce Early Termination 69 Launches Innovative 69 Announces Refinancing 69 Substantially Increases 69 Enter Into 69 TSX Delisting Review 69 Issues Statement Regarding 69 Signs Lease 69 Strengthens Balance Sheet 69 Rated Speculative Buy 69 Signs Definitive 69 Announce Joint Venture 69 Continues Expansion 69 Receives CE Marking 69 Provides Operational Update 69 Evaluate Strategic Alternatives 69 Receives Notice From 69 Significantly Improves 69 Enters Into 69 Discontinues 69 Announces Formation 69 Successfully Completes Tender Offer 69 Announces Dismissal 69 Submits Biologics License Application 69 Settles Litigation 69 Announces Additions 69 Issues Clarification 69 Announces Presentation 69 Trading Halt 69 Resubmits 69 Subsidiary Completes 69 Completes Sale Of 69 Announces Repurchase 69 Formalizes 69 Gets FDA Clearance 69 Significantly Increases 69 Releases Third Quarter 69 Receives Approvable Letter 69 Launches Enhanced 69 Announces Dividend 69 Completes Second Tranche 69 Q1 Loss Widens 69 Aquires 69 Successfully Concludes 69 Expands Presence 69 Signs MOU 69 Announces Share Repurchase 69 Previously Announced 69 Holds Annual Meeting 69 Winning Streak Continues 69 Reports Third Quarter 69 Commences Phase 69 Secures Contract 69 Restructures Debt 69 Expands Into 69 Temporarily Suspends 69 Announces Debt Settlement 69 Grants Options 69 Acquires Exclusive 69 Acknowledges Receipt 69 Declares Quarterly Dividends 69 Taglich Brothers Initiates Coverage 69 Reduces Debt 69 Nears Completion 69 Receives Notice Regarding 69 Announces Bought Deal 69 Announces Appointment 69 Extends Collaboration 69 Net Loss Widens 69 Signs LOI 69 Granted Orphan Drug 68 Announces 68 Delist From 68 Announces Mailing 68 Receives Approval From 68 Q4 Profit Rises 68 Increases Stake 68 Declares Quarterly 68 Therapeutic Competitors Companies 68 Subsidiary Awarded 68 Announces Tentative Approval 68 Announces Resignation 68 Receives Tentative Approval 68 Provides Guidance 68 Announces Operational Update 68 Enters Into Strategic 68 Announces Third Quarter 68 Recieves 68 Finalizes Sale 68 Welcomes Analyst Initiation 68 Completes Due Diligence 68 Maintains Strong 68 BioSante Pharmaceuticals Announces 68 Completes Non Brokered 68 Introduces Next Generation 68 Shares Surge 68 Announces Effectiveness 68 Successfully Completed 68 Q2 Profit Rises 68 Stays Neutral 68 Begin Trading 68 Retains Investor Relations 68 Signs Memorandum 68 Reveals Positive 68 Receives Prestigious 68 Announces Launch 68 Sets Quarterly Dividend 68 Trend Continues Down 68 Receives Stockholder Approval 68 Releases Second Quarter 68 Amend Merger Agreement 68 Announces Enhancements 68 Announces Addition 68 Initiates Clinical 68 Announces Spin Off 68 Achieves Certification 68 Explore Strategic Alternatives 68 Expands Capabilities 68 Announces Recapitalization 68 Mails Offer 68 Private Placement Closed 68 Provides Shareholder 68 Net Loss Narrows 68 Launches Next Generation 68 Signs License Agreement 68 Presents Positive Preclinical 68 Signs Purchase Agreement 68 Completes Installation 68 Subsidiary Purchases 68 Acquire Remaining 68 Declares Increase 68 Completes Recapitalization 68 Shareholders Approve Sale 68 Finalizes 68 Renews Agreement 68 Shares Soar 68 Initiates Clinical Trials 68 Completes Buyout 68 Q4 Profit Declines 68 Identifies Potential 68 Receives Order 68 Acquires 68 Reports Profitable 68 Enters Into License Agreement 68 Enters Into Definitive 68 Recommences 68 Increases Presence 68 Sells Shares 68 Approve Merger 68 CRWEWallstreet.com Stock Report 68 Commences Tender Offer 68 Announces Departure 68 Inks MOU 68 Underwriters Exercise 68 Announces Second Quarter 68 Extends Offer 68 Subsidiary Enters Into 68 Q3 Profit Surges 68 Announces Quarterly 68 Q2 Profit Declines 67 Enters Into Exclusive 67 Engages Investor Relations 67 SWOT Analysis Aarkstore Enterprise 67 Secures Funding 67 Q1 Profit Rises 67 Completes Restructuring 67 Has Commenced 67 Seek Shareholder Approval 67 Receives 67 Mutually Agree 67 Achieves ISO # 67 Wolf Haldenstein Investigating 67 Sign License Agreement 67 Wins Contract 67 Reaches Agreement 67 Q3 Profit Rises 67 Initiates 67 Receives Notification From 67 Strengthens Presence 67 Closes Non Brokered 67 Q4 Profit Surges 67 Declares Increased 67 Patent Issued 67 Reports Second Quarter 67 Acquire Majority 67 Has Received 67 Redeems 67 Submits Response 67 Increases Capacity 67 Signs Agreement 67 Enters Joint Venture 67 Re Affirms 67 Completes Reorganization 67 Finalizes Contract 67 Successfully Launches 67 Files Definitive Proxy 67 Licenses Novel 67 Issues Guidance 67 Successfully Complete 67 Announces Publication 67 Amends Credit 67 Rejects Unsolicited 67 Bearish Speculation 67 Earnings Postmortem 67 Streamlines Operations 67 Bearish MACD 67 Acquires Majority Stake 67 Stock Upgraded 67 OTCStockExchange.com Stock Alert 67 Secures Long Term 67 Successfully Completes Acquisition 67 Expands Distribution 67 Concludes Acquisition 67 Announce Shareholder Approval 67 Initiates Phase III 67 Expands Capacity 67 Provides Comprehensive 67 Host Third Quarter 67 Terminates 67 Achieves Prestigious 67 Q3 Profit Declines 67 Receives Certification 67 Annouces 67 Signs Binding Letter 67 Restructures Operations 67 Celebrates Opening 67 Declares Common 67 Enters Negotiations 67 Largest Shareholder 67 Demonstrates Positive 67 Continues Aggressive 67 Subsidiary Awarded Contract 67 Declares Quarterly Cash 67 Extends Term 67 Signs Letter 67 Subsidiary Expands 67 Completes Transition 67 Acquire Controlling Interest 67 Announces Quarterly Dividend 67 Corporation Announces Pricing 67 Commences Cash 67 Miraculins Announces 67 Equity Preview 67 Novartis Novo Nordisk 67 Completes Integration 67 Calls Purchased 67 Expands Scientific Advisory 67 Enters Into Negotiations 67 More Than Doubles 67 Announce Signing 67 Expand Into 67 Q1 Profit Surges 67 Directors Authorizes 67 Acquires Majority 67 Settle Patent Dispute 67 Subsidiary Wins 67 Enters Into Merger Agreement 67 Provides Updated 67 Stock Downgraded 67 Expects Higher 67 Announces Tender Offer 67 PPD Declares 67 Furthers 67 Files Amended 67 Shareholders Elect 67 Q1 Profit Declines 67 Announce Settlement 67 Buys Majority Stake 67 Receives Favorable Ruling 67 Files Registration Statement 67 Submits Proposal 67 Secures 66 Declares Fourth Quarter 66 Acquire Stake 66 Declares Dividend 66 Proudly Announces 66 Pending Acquisition 66 Achieves SAS 66 Regains Nasdaq 66 Declares Cash Dividend 66 Stockholders Approve Merger Agreement 66 Files Annual Report 66 Bearish Pressure Building 66 Downtrend Spotted 66 Renews Contract 66 otcstockexchange.com 66 Demonstrates Significant 66 Flamel Technologies Announces 66 Reminds Shareholders 66 Alert Technicals Showing Bearish 66 FDA Approves 66 Finalises 66 Terminate Merger Agreement 66 PROFILE CO 66 Announces Rebranding 66 Acquires Remaining 66 Begins Drilling 66 Host Fourth Quarter 66 Drilling Underway 66 Shareholders Approve Arrangement 66 Enlarges 66 Planned Acquisition 66 Receives Orphan Drug 66 Bearish Average Crossover 66 Trend Continues Lower 66 Declares Second Quarter 66 Submits 66 Updates Guidance 66 Posts Strong 66 Bearish Technical 66 Arranges Private Placement 66 Presents Preclinical 66 Closes Oversubscribed 66 Announces Fourth Quarter 66 Expands Portfolio 66 Engages CHF Investor Relations 66 Reschedules Fourth Quarter 66 Closes Buyout 66 Q2 Profit Surges 66 Reaffirms Commitment 66 Have Been Added 66 Enters Into Licensing Agreement 66 Increases Quarterly Dividend 66 Submits Supplemental 66 Host Second Quarter 66 Announces Pricing 66 Retains Leading 66 Q1 Adj 66 Arranges 66 Submits IND 66 Inks Deal With 66 Declares Initial 66 Confirms Commitment 66 Introduces Revolutionary 66 Taro Receives 66 Declares Regular Quarterly 66 Enters Into Joint Venture 66 Ups Stake 66 Undertakes 66 Awarded Contract 66 Introduces Expanded 66 Relocates Corporate Headquarters 66 Present Preclinical Data 66 Commences Initial 66 Expands 66 Enters Definitive Agreement 66 Exercises Warrants 66 Announce Filing 66 Announce Initiation 66 Bullish Engulfing Pattern 66 Q4 Profit Decreases 66 Options Trader Alert 66 Presents Preclinical Data 66 Significant Increase 66 Discloses 66 Ink Deal 66 Announces Voluntary Delisting 66 Announces Availability 66 Bullish Speculation 66 Shareholders Approve Plan 66 Approves Merger 66 FY# Loss Narrows 66 Announces Conditional Approval 66 Successful Completion 66 Sign Definitive Merger 66 NewsBite Downgrade Puts Pressure 66 Initiates Dosing 66 Receives Delisting Notice 66 Releases Next Generation 66 Thewallstreetleader.com Profiles 66 Crowflight Announces 66 Corporation Declares Regular 66 Awarded Contracts 66 Signs Joint Venture 66 Obtains Extension 66 Commence Phase 66 Reports Assay Results 66 Puts Purchased 66 Expand Relationship 66 Files Investigational 66 Initiates Voluntary Recall 66 Announces Definitive Merger 66 Wins Prestigious 66 Submits NDA 66 Bullish Average Crossover 66 Post Earnings Checkup 66 Wholly Owned Subsidiary 66 Voluntarily Delist 65 Trend Continues Up 65 Announce Expanded 65 Extends Reach 65 Initiates Drilling 65 Receives ISO #:# [002] 65 Progresses 65 Commences Phase III 65 Skymark Research Initiates Independent 65 A.M. Best Affirms Ratings 65 Achieves Record 65 Fully Subscribed 65 Investigates Proposed Acquisition 65 Patent Covering 65 Increases Quarterly Cash Dividend 65 Amends Merger Agreement 65 HSR Waiting Period 65 Doubles Size 65 Q4 Profit Soars 65 Gets Bearish Confirmation 65 Withdraws Offer 65 Uptrend Spotted 65 Announcement Regarding 65 Merger Approved 65 Declares Quarterly Cash Dividend 65 Voluntarily Withdraws 65 Authorizes Additional 65 Posts Wider Loss 65 Announces Ticker Symbol 65 Stock Soars 65 Raises Bid 65 TSX Delisting 65 Directors Declares Dividend 65 Reports Record 65 ISS Recommends 65 Obtains Financing 65 Fortifies 65 Announces Immediate Availability 65 Announces Definitive Agreements 65 Secures Patent 65 Successfully Tests 65 Obtains Patent 65 Bullish Technical Alert 65 Begins Dosing 65 Underpins 65 Sets Annual Meeting 65 Signs Non Binding 65 Declares Regular 65 Shareholder Opinions 65 Extends Contract 65 BenchmarkJournal.com Sector Analysis 65 Exploring Strategic Alternatives 65 Reaches Settlement Agreement 65 Changes Ticker Symbol 65 Receives Funding 65 Declares Dividend Increase 65 Daytradersdigest.com 65 FDA Accepts 65 Files Voluntary 65 Realigns 65 Files Preliminary Proxy 65 Alert Technicals Showing Bullish 65 Begins Shipment 65 Dutton Associates Announces 65 Announce Collaboration 65 Director Exercises Options 65 Submits Revised 65 Finalizes Joint Venture 65 Its Previously Announced 65 Officially Opens 65 News Unternehmensnachrichten 65 Proposes Merger 65 Receives Initial 65 Files Revised 65 Increases Share Repurchase 65 Moves Towards 65 Awarded Patents 65 Initiates Phase 65 Reschedules 65 Statement Regarding 65 Expands Reach 65 Q3 Profit Soars 65 Completes Spin Off 65 Shares Climb 65 Sets Record Date 65 Commences Production 65 Expands Internationally 65 Makes Significant 65 Settle Litigation 65 Forms Strategic 65 Beats Analyst 65 Collaborators Present 65 Cites Positive 65 Swings To 65 Announces Affiliation 65 Quadruples 65 Reports Significantly Improved 65 Announces Brokered Private 65 -gamma secretase modulator 65 Repositions 65 Sweetens Bid 65 Forges Partnership 65 Announces Restatement 65 Reclassifies 65 Completes Debt Refinancing 65 Appoints Experienced 65 Univest Corporation Declares 65 Signs Exclusive 65 Regulators Approve 65 Shareholders Reject 65 Trend Continues Higher 65 Commence Drilling 65 Posts Record 65 Boosts Stake 65 Starts Drilling 65 dedicated CHAT ROOM 65 Commences Offering 65 Commercializes 65 Retains CCG Investor Relations 65 AllPennyStocks.com Spotlights 65 Schedules Second Quarter 65 Revises Fourth Quarter 65 Inks Deal 65 Assets Acquirer Company 65 Executes Letter 65 Achieves Record Sales 65 Signs Long Term 65 Grants Incentive 65 Shareholders Approve Name 65 Earns Prestigious 65 Q4 Profit Plunges 65 Continues Expansion Into 65 Technicals Showing Bearish 65 MONSTERSTOX.COM Monsterstox.com 65 TriCo Bancshares Announces 65 Receives Regulatory Approvals 65 Signs Contract 65 Enters Oversold Territory 65 Provide Comprehensive 65 Lorus Therapeutics Announces 65 Obtains CE Mark 65 Coverage Initiated 65 Declares Third Quarter 65 Establish Joint Venture 65 CybeRelease Decliners 65 Significantly Reduces 65 NYMH Announces 65 Sets Second Quarter 65 Awarded Multi 65 Concludes Successful 65 Introduces Innovative 65 www.otc advisors.com names 65 Welcomes Analyst 65 Declares Regular Quarterly Dividend 65 Develops Innovative 65 Endures Analyst Downgrade 65 CONTINUES LOWER 65 Unveils Revolutionary 65 Registration Statement Declared Effective 64 Smartstox.com Spotlights 64 Bolsters 64 Q1 Profit Decreases 64 CEO Exercises Options 64 Snaps Up 64 Confirms Significant 64 Extends Deadline 64 Moving Average Crossover Alert 64 Rebrands 64 Expands Relationship 64 Amends Private Placement 64 Successfully Tested 64 Mobilizes 64 Canaccord Genuity Reiterates Buy 64 Delivers Next Generation 64 Relocates 64 Second Quarter Profit Rises 64 Report Initiates Independent 64 Finalizes Sale Of 64 Declares Quarterly Dividend 64 Declares Distribution 64 Subsidiary Files 64 &Amp; 64 Analysts Begin Coverage 64 Spins Off 64 Study Demonstrates 64 Spins Out 64 Directors Unanimously Rejects 64 Annual Meeting Date 64 Arranges Financing 64 Reports Preclinical Data 64 Interesting Options Volume 64 Pinnacle Digest Looking 64 Receives Anticipated 64 Gets Clearance 64 Moves Forward 64 Increases Cash Dividend 64 Increases Private Placement 64 Receives Accreditation 64 Completes Drilling 64 Increases Non Brokered 64 Demonstrates Long Term 64 Restate Financial 64 Revises Guidance 64 Entered Into 64 Explores Strategic Alternatives 64 Bearish Moving Average 64 Receives ISO #:# [001] 64 Announces Participation 64 Finalize Joint Venture 64 Adopts Stockholder Rights 64 Trading Halted 64 Sells Portion 64 Validates 64 Broadens Its 64 Q3 Adj 64 Enters Strategic 64 Announces Quarterly Dividends 64 Successfully Implements 64 Zacks Analyst Blog Highlights 64 Achieves Positive 64 Gets Tentative 64 Reinforces 64 Extends Expiration 64 Jointly Develop 64 Posts Large 64 Successfully Deploys 64 Rises Quick Facts 64 Results Confirm 64 Inks Licensing Deal 64 Launches Website 64 Q2 Adj 64 Launches Redesigned Website 64 CONFERENCE CALLS SOURCE 64 Appoints 64 Drilling Completed 64 Upgrades Ratings 64 please visit http:/www.stockguru.com 64 Closes Over Allotment 64 Ups Bid 64 Expansion Continues 64 Other OTC USOG 64 Activity Alert 64 Enters Into Collaboration 64 Receives Complete Response 64 Announces Partial Redemption 64 Announces Upcoming 64 Terminate Agreement 64 Achieves ISO #:# Certification [002] 64 Guides Inline 64 Guides Below 64 Anounces 64 Receives Positive Results 64 Receives Requisite Consents 64 Drug Candidate 64 Unitholders Approve 64 Monetizes 64 Q3 Profit Drops 64 Clears Path 64 Extends Relationship 64 1st Writethru 64 Enter Into Definitive 64 CONTINUES UP 64 Strongly Supports 64 Marks Milestone 64 Trade Resumption 64 Earns Milestone Payment 64 Announces Stock Buyback 64 Expand Presence 64 Schedules Third Quarter 64 Raises Stake 64 Posts Higher 64 Anworth Announces 64 Movers Roundup 64 Settles Dispute With 64 Expands Footprint 64 Million Private Placement 64 Ink Pact 64 Unsolicited Proposal From 64 Announces Favorable Ruling 64 Posts 4Q 64 Canaccord Genuity Maintains Buy 64 Renames 64 Initiates Coverage 64 Begins Shipping 64 Revolutionizes 64 Q2 Profit Soars 64 Signs Pact 64 DayTradersDigest.com Profiles 64 Unusual Trading 64 FDA Panel Recommends 64 Achieves ISO 64 Settle Patent Litigation 64 4Q Loss Widens 64 Completes Offering 64 Up Slightly 64 Shares Plunged What 64 Receives Marketing Authorization 64 Divests 64 Shows Promise 64 Regulatory Approvals 64 Signs Binding Agreement 64 Files Patent 64 Retains 64 Increases Dividend 64 Medoro Resources Announces 64 Withdraws Proposal 64 Sees Continued 64 Submits Bid 64 Acquires Controlling Stake 64 Strengthens Leadership 64 INDICATED LOWER 64 Flagstone Re Announces 64 Reduces Risk 64 1st Quarter Results 64 Declares Quarterly Common 64 TheWallStreetLeader.com Profiles 64 Signs Definitive Merger Agreement 64 Delays Filing 64 Identifies Significant 64 Holders Approve 64 Reaches Milestone 64 Acquires Stake 64 Forges Ahead 64 Amends Tender Offer 64 Unveils Next Generation 64 Shares Plummet 64 Forms Joint Venture 64 Extends Presence 64 Subscribes 64 Meets Primary Endpoint 64 Announce Appointment 64 Releases Latest 64 Initiating Coverage 64 Underwriters Exercise Over Allotment 64 Fancamp Announces 64 Q1 Profit Plunges 64 Remain Listed 64 Widens Quick Facts 64 Commences Drill Program 64 Improves Survival 63 Buyers Accumulating Shares 63 Establishes Presence 63 Becomes Effective 63 CORRECTION FROM SOURCE 63 Powerful Buy 63 #.#.# Meldung [001] 63 Moves Toward 63 Procures 63 Inks Agreement 63 #.#/Share [002] 63 Takes Delivery 63 Announces Tender Offers 63 Commences Mailing 63 Reveals Receipt 63 Sells Majority Stake 63 Canada Trading Halt 63 Announce Termination 63 :/ finance.yahoo.com q 63 Resumes Drilling 63 Accelerates Growth 63 Reaffirms 63 Announces Fiscal 63 Disposes 63 Inc. Rated Speculative 63 Restructures 63 Corp. Joins OTCQX 63 Nearing Completion 63 Certifies 63 Restates